TSS
WINT

Two Sigma Securities’s Windtree Therapeutics WINT Stock Holding History

Two Sigma Securities’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19
Closed -$21.1K – 3546
2023
Q2 		$21.1K Buy
+19
New +$38.6K ﹤0.01% 2498
2023
Q1 		– Hold
0
– -$3.22K – 3351
2022
Q4 		– Sell
-1
Closed -$8.89K – 2490
2022
Q3 		$14K Buy
+1
New +$17.9K ﹤0.01% 2349
2021
Q3 		– Hold
0
– -$23K – 2010
2021
Q2 		– Hold
0
– – – 1444

Other funds holding WINT

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Two Sigma Securities's WINT Position: Q3 2023 in Review

Two Sigma Securities sold out of Windtree Therapeutics (WINT) in Q3 2023, closing a stake of 19 shares — an estimated $21.1K sold.

Two Sigma Securities first reported a position in WINT in Q3 2022 and held it in 2 quarters. The position peaked at $21.1K in Q2 2023. 5 funds tracked by Wall St. Rank hold WINT as of Q3 2023.

  • Two Sigma Securities reported no remaining Windtree Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Securities sold 19 Windtree Therapeutics shares in Q3 2023, an estimated $21.1K.
  • Two Sigma Securities first reported a position in Windtree Therapeutics in Q3 2022 and held it in 2 quarters.
  • Two Sigma Securities's Windtree Therapeutics position peaked at $21.1K in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.